Patent · US Active

HER3/HER2 bispecific antibodies binding to the beta-hairpin of HER3 and domain II of HER2

US10808038B2 · kind B2 · utility

0Cited by

7References

6Claims

0Family size

Assignee

Hoffmann-La Roche Inc. · US

Inventors

Birgit Bossenmaier · Hanerau-Hademarschen, DE
Richard Buick · Belfast, GB
Stefan Dengl · Munich, DE
Michael Gerg · Munich, DE
Carmen Peess · Tutzing, DE
Wolfgang Schaefer · Sankt Augustin, DE
Michael Schraeml · Penzberg, DE
Claudio Sustmann · Munich, DE

Key dates

Filing date	Nov 10, 2016
Grant date	Oct 20, 2020
Priority date	—
Expiry date	Nov 10, 2036

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/94
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to HER3/HER2 bispecific antibodies binding to the beta-hairpin of HER3 and domain II of HER2, their preparation and use as medicament.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.